Acalabrutinib Versus Chlorambucil Plus Rituximab in Patients with Previously Untreated Chronic Lymphocytic Leukemia: A Randomized, Multicenter, Open-Label, Phase 3 Study
Year: 2024
Type: conference-abstract
Source: Blood
Authors: Lugui Qiu, Zhuogang Liu, Shuhua Yi, Thanh Nguyen, Wen-Juan Yu, Keshu Zhou, Haiwen Huang, Udomsak Bunworasate, Man Huynh, Hui Zhou, Su-Peng Yeh, Yiqiu Wang, Xiaofeng Liu, Wei Fu
Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, Sheng Jing Hospital, China Medical University, First Affiliated Hospital Zhejiang University, Zhejiang University, Zhengzhou University, Henan Cancer Hospital, First Affiliated Hospital of Soochow University, Chulalongkorn University, Central South University, Hunan Cancer Hospital, China Medical University, China Medical University Hospital
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405041232